Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Cognitive Therapy

Cognitive Therapy

Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Bipolar Disorder

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Performance and Psychometric Properties of Novel Brief Assessments for Depression in Children and Adolescents.

JAACAP open·2025

Same author

Reducing physical assaults on residents through implementation of project BETA: Best practices in the evaluation and treatment of agitation.

AEM education and training·2025

Same author

The Quick Inventory of Depressive Symptomatology, Adolescent Version (QIDS-A<sub>17</sub>): A Psychometric Evaluation.

Neuropsychiatric disease and treatment·2023

Same author

Improving the management of acutely agitated patients in the emergency department through implementation of Project BETA (Best Practices in the Evaluation and Treatment of Agitation).

Journal of the American College of Emergency Physicians open·2020

Same author

Two Trajectories of Depressive Symptom Reduction Throughout Behavioral Activation Teletherapy Among Underserved, Ethnically Diverse, Primary Care Patients: A VitalSign<sup>6</sup> Report.

Behavior therapy·2020

Same author

Association of anger attacks with suicidal ideation in adults with major depressive disorder: Findings from the EMBARC study.

Depression and anxiety·2020

Search research articles

Related Experiment Video

Updated: May 29, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Measurement-based care for unipolar depression.

David W Morris¹, Madhukar H Trivedi

¹Department of Psychiatry, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9119, USA.

Current Psychiatry Reports

|September 22, 2011

Summary

Measurement-based care (MBC) optimizes antidepressant treatment for unipolar depression by monitoring key factors like dosage and symptoms. This approach enhances patient outcomes and treatment response through systematic assessment and management.

More Related Videos

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Related Experiment Videos

Last Updated: May 29, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Area of Science:

Psychiatry
Clinical Psychology
Pharmacology

Background:

Unipolar depression management often relies on subjective clinical judgment.
Optimizing antidepressant treatment response requires systematic monitoring of patient progress.
Existing treatment protocols may not fully leverage objective patient data.

Purpose of the Study:

To outline the role and components of measurement-based care (MBC) in managing antidepressant treatment for unipolar depression.
To highlight how MBC can optimize individual treatment strategies and maximize antidepressant response.
To discuss the practical implementation and future potential of MBC systems.

Main Methods:

Utilizing empirically validated assessments to monitor key treatment areas: antidepressant dosage, symptom severity, medication tolerability, adherence, and safety.
Implementing a multi-step process: screening, antidepressant selection, assessment-based medication management, and ongoing care.
Leveraging electronic MBC systems to streamline data collection and management.

Main Results:

MBC provides a structured framework for enhancing antidepressant treatment efficacy.
Validated assessments enable objective monitoring of critical treatment parameters.
Electronic MBC systems reduce the burden on both patients and clinicians.
MBC facilitates personalized treatment adjustments for improved outcomes.

Conclusions:

Measurement-based care is a vital strategy for optimizing antidepressant therapy in unipolar depression.
The systematic integration of validated assessments and electronic systems enhances treatment delivery and monitoring.
Wider adoption of MBC holds significant promise for improving patient care and treatment success rates.